drugset / Trial / NCT07828561

Clinical Outcomes of Intraarticular Platelet-Rich Plasma Injection in Knee Osteoarthritis

NCT07828561 ↗

Completed 59 enrolled KIST Medical and Teaching Hospital
NaSingle-groupOpen-labelTreatment

Summary

This prospective single-arm interventional study was designed to assess the short-term clinical outcomes of intra-articular platelet-rich plasma (PRP) injections in patients with Kellgren-Lawrence grade II and III knee osteoarthritis. A total of 59 patients (61 knees) were enrolled and followed for six months. Pain and function were measured using the Visual Analogue Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Safety monitoring included documentation of injection-site pain and other adverse events.

Timeline

Start
2022-11-05
Primary completion
2023-11-05
Completion
2023-11-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 5 ml Other

Indications